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The kidneys play a key role in the homeostasis of body water and electrolyte balance.
Aquaporin-2 (AQP2) is the vasopressin-regulated water-channel protein expressed at the
connecting tubule and collecting duct, and plays a key role in urine concentration and
body-water homeostasis through short-term and long-term regulation of collecting duct
water permeability. The signaling transduction pathways resulting in the AQP2 trafﬁck-
ing to the apical plasma membrane of the collecting duct principal cells, including AQP2
phosphorylation, RhoA phosphorylation, actin depolymerization, and calcium mobiliza-
tion, and the changes of AQP2 abundance in water-balance disorders have been
extensively studied. Dysregulation of AQP2 has been shown to be importantly associated
with a number of clinical conditions characterized by body-water balance disturbances,
including hereditary nephrogenic diabetes insipidus (NDI), lithium-induced NDI, electro-
lytes disturbance, acute and chronic renal failure, ureteral obstruction, nephrotic
syndrome, congestive heart failure, and hepatic cirrhosis. Recent studies exploiting omics
technology further demonstrated the comprehensive vasopressin signaling pathways in
the collecting ducts. Taken together, these studies elucidate the underlying molecular
mechanisms of body-water homeostasis and provide the basis for the treatment of body-
water balance disorders.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The kidneys play a key role in the homeostasis of body water
and electrolyte balance. Water is reabsorbed as urine passes
through the renal tubules. Absorption in the renal tubule depends
on the driving force for water reabsorption and osmotic equili-
bration of water across the tubular epithelium. Accordingly,
transcellular water transport across the renal tubular epithelial
cells is essential to the homeostasis of body-water balance.
Approximately, 180 L/day of glomerular ﬁltrate is produced in
an adult human, and the majority of glomerular ﬁltrate is
constitutively reabsorbed by the proximal tubules and descendingn Society of Nephrology. Publi
c-nd/4.0/).
mistry and Cell Biology, Scho
.thin limbs of Henle′s loop, where aquaporin-1 (AQP1) is abun-
dantly present at both the apical and basolateral membranes of
the epithelia. The ascending thin limbs and thick limbs are
relatively impermeable to water and they deliver the tubular
ﬂuid into the distal convoluted tubules, connecting tubule seg-
ments, and collecting ducts. In particular, the collecting ducts are
importantly involved in the regulation of body-water balance,
because vasopressin-regulated water reabsorption occurs in this
segment. Basal epithelial water permeability in the collecting duct
principal cells is low, but water permeability can increase to very
high levels, when principal cells are stimulated by arginine
vasopressin (AVP, also known as antidiuretic hormone).shed by Elsevier. This is an open access article under the CC BY-NC-ND
ol of Medicine, Kyungpook National University, Taegu 700-422, Korea.
Figure 1. Immunoﬂuorescence microscopy of AQP2 in the inner
medullary collecting duct of rat kidney. The AQP2 is localized at the
apical plasma membrane and intracellular vesicles in the inner medul-
lary collecting duct cells, indicated by arrows. AQP2, aquaporin-2.
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all biomembranes have some degree of water permeability,
water channels have to exist in the cells having high water
permeability, such as red blood cells and renal tubular epithelial
cells. The discovery of the ﬁrst water-channel protein (AQP1)
provided an answer to the important biophysical question of
how water speciﬁcally and rapidly crosses biomembranes [1–3].
Moreover, complementary DNAs for many of the important
transporters localized at the renal tubules were cloned and
sequenced [4]. Thirteen mammalian AQPs are now known [5–7],
and they can be classiﬁed into three major subtypes, which are
mainly determined by their transport capabilities: (1) the
classical AQPs (AQP1, AQP2, AQP4, and AQP5), which are
water-selective channels transporting onlywater; (2) aquaglycer-
oporins (AQP3, AQP7, AQP9, and AQP10), which are permeated
by small uncharged molecules in addition to water; and
(3) unorthodox AQPs (AQP6, AQP8, AQP11, and AQP12), whose
function is currently being elucidated. Of the known AQPs, eight
AQPs (AQP1, AQP2, AQP3, AQP4, AQP6, AQP7, AQP8, and AQP11)
are expressed in the mammalian kidney. In the present review,
we will focus on the regulation of AQP2, which is the
vasopressin-regulated water-channel protein expressed at the
connecting tubule and collecting duct, and plays a key role in
urine concentration and body-water homeostasis.Expression of AQP2 in the kidney collecting duct
AQP2 is abundantly expressed at the apical plasma membrane
and subapical vesicles in the principal cells of the kidney
collecting duct (Fig. 1) and less abundantly expressed in the
connecting tubules [8]. In addition, some AQP2 immunolabeling
has also been found to be associated with the basolateral plasma
membrane [9,10]. AQP2 is the target protein for vasopressin-
regulated water permeability in the collecting ducts [11–14]. This
ﬁnding was established by the studies revealing a direct correla-
tion between AQP2 expression at the apical plasma membrane
and collecting duct water permeability in isolated tubule studies
in response to vasopressin stimulation [12] and studies demon-
strating that humans with mutations in the AQP2 gene [15,16] or
rats with profound nephrogenic diabetes insipidus (NDI) [17–19]
exhibited massive polyuria and impaired urinary concentrating
capacity. Moreover, a severe urinary concentrating defect and
postnatal death were directly observed in AQP2 gene-deﬁcient
mice [20]. This indicates that AQP2 plays an essential role in renal
tubular water reabsorption in both the connecting tubule and
the collecting ducts. Consistent with this, dysregulation of AQP2
is importantly associated with a number of clinical conditions
exhibiting body-water balance disturbance, including hereditary
NDI, lithium-induced NDI, electrolytes disturbance, acute and
chronic renal failure, ureteral obstruction, nephrotic syndrome,
congestive heart failure, and hepatic cirrhosis [16,21–24].Regulation of renal AQP2 by vasopressin
The signaling transduction pathways resulting in the AQP2
trafﬁcking to the apical plasma membrane of the collecting
duct principal cells and the changes to AQP2 abundance during
times of water-balance disorders have been extensively studied
(Table 1). AQP2 plays a key role in both short-term regulation
and long-term adaptation of collecting duct water permeability
[12,14,25–29]. Short-term regulation is the process by whichvasopressin rapidly increases water permeability of the collecting
duct principal cells by stimulating vasopressin V2 receptor (V2R)
in the basolateral plasma membrane and translocation of AQP2
from intracellular vesicles to the apical plasma membrane. This
response was measured within 5–30 minutes after increasing the
peritubular vasopressin concentration [30,31]. Long-term adap-
tation of collecting duct water permeability is seen when
circulating vasopressin levels are increased over a period of
hours to days, resulting in an increase of the AQP2 abundance
per cell in the collecting ducts [25,27,28]. This process allows
urine concentration and is essential for water-balance home-
ostasis. In addition, recent studies demonstrated that ubiquitina-
tion and subsequent proteasomal and/or lysosomal degradation
of AQP2 could play a critical role in the regulation of AQP2
abundance [32–34]. The degradation pathways, therefore, bal-
ance the abundance of AQP2.Vasopressin-induced AQP2 trafﬁcking
An increase in blood osmolality and/or a decrease in blood
volume trigger the neurohypophyseal release of vasopressin
[35]. Isolated perfused renal collecting ducts demonstrated
that AVP induces a rapid increase in the osmotic water
permeability of the epithelium. Kinetic studies in isolated
perfused inner medullary collecting ducts (IMCDs) revealed
an increase in osmotic water permeability after only 40 sec-
onds of incubation at 37 1C, and half of the maximal water
permeability was reached within 10 minutes [31]. The increase
in water permeability of the collecting duct epithelium is a
result of translocation of AQP2 from subapical vesicles to the
apical plasma membrane [12,25]. In the absence of AVP, most
of the AQP2 resides in intracellular vesicles thought to
be recycling endosomes [36]. This was demonstrated by the
ﬁndings of colocalization of AQP2 and Rab11 protein, a marker
of apical recycling endosomes [36]. By contrast, immunoelec-
tron microscopy revealed that AVP stimulation resulted in
a ﬁvefold increase in the appearance of AQP2 immunogold
particles in the apical plasma membrane accompanied by
a markedly decreased immunogold labeling of intracellular
AQP2 [12]. This redistribution was associated with an increase
in osmotic water permeability of similar magnitude [12]. These
Table 1. Intracellular signaling pathways for AQP2 trafﬁcking or
endocytosis
Trafﬁcking
cAMP/PKA signaling pathway [27,40]
Intracellular calcium (Ca2+) mobilization
(calcium–calmodulin-mediated myosin activation) [78]
PI3K-dependent activation of Akt [87]
AS160 Phosphorylation [73]
RhoA-dependent cytoskeletal dynamics [88]
Endocytosis
Clathrin-mediated endocytosis [89]
Ubiquitination of AQP2 C-terminus at K270 [33,34]
PGE2, dopamine [52,67]
AQP2, aquaporin-2; cAMP, cyclic adenosine monophosphate; PGE2,
prostaglandin E2; PKA, protein kinase A.
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sin in rats, which also caused translocation of AQP2 to the
apical plasma membrane of collecting duct principal cells [37]
or vice versa upon withdrawing vasopressin stimulation [34].
The vasopressin signaling network between vasopressin
stimulation and AQP2 trafﬁcking to the apical plasma mem-
brane has been identiﬁed [38]. Insertion of AQP2 at the apical
plasma membrane is induced by vasopressin binding to the
V2R expressed at the basolateral plasma membrane of the
collecting duct principal cells. This activates G proteins, which
stimulate adenylyl cyclase, resulting in increased intracellular
cyclic adenosine monophosphate (cAMP) concentration and
activation of protein kinase A (PKA). AQP2 contains a PKA
phosphorylation consensus site at serine 256, and phosphor-
ylation of the serine 256 in three of four AQP2 monomers in an
AQP2 heterotetramer is involved in the regulated translocation
of AQP2 to the apical plasma membrane [39,40]. A number of
proteins have been demonstrated to be involved in the cAMP-
dependent AQP2 trafﬁcking, such as PKA-anchoring proteins
(AKAPs), phosphodiesterases (PDEs), cytoskeletal components
(F-actin and microtubules), small guanosine triphosphatases
(GTPases) of the Rho family, motor proteins transporting
AQP2-bearing vesicles, vesicle-targeting receptors (soluble
N-ethylmaleimide-sensitive factor attachment protein recep-
tor or SNAREs), and 70-kDa heat-shock protein [41,42].AQP2 phosphorylation in vasopressin-stimulated AQP2
translocation to the plasma membrane
V2R-mediated cAMP/PKA signaling has been demonstrated
to be one of the principal pathways to induce AQP2 trafﬁcking
and expression [22,40]. Stimulation of V2R by AVP at the
basolateral plasma membrane of the collecting duct principal
cells triggers activation of Gsα-mediated adenylyl cyclase activ-
ity [43]. Sequentially, increased intracellular cAMP concentra-
tion and PKA activation result in recruitment of PKA to AQP2-
containing vesicles by AKAPs [44]. In fact, AKAP18 delta has
been shown to colocalize with AQP2 in intracellular vesicles
[45]. In addition, rolipram-mediated inhibition of the cAMP-
speciﬁc PDE4D increases AKAP-tethered PKA activity in AQP2-
bearing vesicles and enhances AQP2 trafﬁcking [46]. This
ﬁnding suggested that a compartmentalized cAMP-dependent
signal transduction pathway consisting of anchored PDE4D,
AKAP18 delta, and PKA plays a role in AQP2 trafﬁcking [47].
AQP2 contains a consensus site for PKA phosphorylation
(RRQS) in the cytoplasmic COOH terminus at seine 256 (S256),which has been shown to be critical for vasopressin-induced cell-
surface accumulation of AQP2 [48,49]. This has been demon-
strated by mutational analysis. The AQP2-S256A mutant cannot
be phosphorylated by PKA and it does not trafﬁc to the plasma
membrane in response to cAMP-elevating agents [40,50]. By
contrast, the AQP2-S256D mutant, mimicking phosphorylation,
resides in the plasmamembrane, independent of cAMP level [50].
Interestingly, immunoelectron microscopy revealed that phos-
phorylated AQP2 (at serine 256) is localized in both the plasma
membrane and intracellular vesicles [51], suggesting that even in
low-circulating vasopressin states it is constitutively phosphory-
lated, and/or the phosphorylation of AQP2 at serine 256 per se is
not sufﬁcient to translocate AQP2 to the plasma membrane or to
maintain AQP2 at the plasma membrane. In Madin-Darby Canine
Kidney (MDCK) cells expressing AQP2-S256D, its internalization
was induced by treatment of the PKA inhibitor H89 [52]. This
ﬁnding suggested that PKA-dependent phosphorylation of other
regulatory proteins could also be involved in the regulation of
AQP2 trafﬁcking or maintaining AQP2 in the plasma membrane.
Moreover, dopamine and prostaglandin E2 (PGE2) cause inter-
nalization of the AQP2-S256D mutant [52].
Recently, phosphoproteomics studies have revealed that in
addition to S256, AQP2 is further phosphorylated on residues
S261, S264, and S269 [53] in response to AVP stimulation.
Immunoelectron microscopy demonstrated that these phos-
phorylated forms of AQP2 are localized to different intracellular
compartments [54,55]. The precise role that these additional
phosphorylation sites play remains undeﬁned [55]. Although
phosphorylation of AQP2 at S256 is important in AQP2 trafﬁck-
ing, it remains unclear as to how the phosphorylated AQP2
actually causes intracellular trafﬁcking. One possibility is that
phosphorylation of AQP2 directly inﬂuences an interaction
between AQP2-containing vesicles and the cell cytoskeleton,
microtubules, or accessory crosslinking proteins. Indeed, S256 is
important for a direct interaction of AQP2 with 70-kDa heat-
shock protein and, ultimately, the AQP2 trafﬁcking [41]. More-
over, a recent study revealed that forskolin-induced AQP2
phosphorylation (S256) was not signiﬁcantly induced in the
mpkCCD cells with small interfering RNA (siRNA)-directed
knockdown of 70-kDa heat-shock protein [42]. Alternatively,
phosphorylation might attenuate AQP2 endocytosis, leading to
an accumulation at the cell surface [56].Retrieval of AQP2 from the plasma membrane and
possible role of ubiquitination in AQP2 degradation
In contrast to the relatively well-established pathways
involved in vasopressin-regulated AQP2 trafﬁcking and de novo
synthesis of AQP2, retrieval of AQP2 from the plasma mem-
brane and intracellular degradation of the proteins including
AQP2 are poorly understood. During endocytosis of AQP2, it
accumulates in clathrin-coated pits prior to being internalized
through a clathrin-mediated process [57–59]. Internalization of
AQP2 is likely to be independent on its phosphorylation state.
For example, both PGE2 and dopamine can promote removal of
AQP2 from the cell membrane despite the phosphorylation
state of AQP2 [52,60]. Furthermore, PKC activation mediates
AQP2 endocytosis independent of phosphorylation state [50].
Once internalized, AQP2 is retrieved to EEA1-positive early
endosomes through a phosphatidylinositol-3-kinase (PI3K)-
dependent mechanism prior to being transferred to Rab11-
positive recycling vesicles [61]. The actin ﬁlament is involved in
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accumulation of AQP2 in the EEA1-positive early endosomes
[62]. Following AVP restimulation, AQP2 may be recycled to the
apical plasma membrane, a process that is thought to involve
the protein Rab11 [62,63]. Interestingly, despite the disruption
of microtubules, AQP2 in Rab11-positive vesicles respond to
AVP stimulation, resulting in AQP2 trafﬁcking [36,62]. The Rab
family of proteins are known to play an important role in
intracellular vesicle trafﬁcking. In the IMCD cells of rat kidney,
proteomic analysis of AQP2-expressing vesicles previously
revealed the expression of a number of Rab proteins including
Rab2, Rab10, and Rab14 [63]. Moreover, transcriptome analysis
of rat kidney IMCD revealed a number of transcripts corre-
sponding to Rab proteins including Rab2, Rab8A, Rab8B, Rab10,
and Rab14 [64]. In addition, immunogold electron microscopy
showed that Rab5, Rab7, and Rab11 are present in AQP2-
immunoisolated vesicles and an immunoblot analysis also
showed that Rab4, Rab5, Rab7, and Rab11 are present in the
AQP2-bearing vesicles [63]. Among them, Rab11, a marker of
apical recycling endosomes, is known to be associated with the
AQP2-storage compartment [65].
Ubiquitination is likely to be important for AQP2 endocytosis
[33]. AQP2 is polyubiquitinated at the plasma membrane on a
single residue (K270), resulting in internalization of AQP2,
transport to multivesicular bodies (MVBs), and subsequent
proteasomal degradation. Consistent with this, either MG132
(a speciﬁc proteasome inhibitor) or chloroquine (a blocker of the
lysosomal pathway of protein degradation) treatment in primary
cultured IMCD cells signiﬁcantly reduced AQP2 degradation [34],
indicating that ubiquitination and subsequent proteasomal and/
or lysosomal degradation of AQP2 plays a critical role in the
regulation of AQP2 abundance. A proportion of AQP2 that is
internalized to MVBs can be excreted into the urine as exosomes
[66]. A recent study demonstrated a proﬁle of genes and proteins
of E3 ubiquitin-protein ligases (E3s) in rat kidney, which could
be involved in the intracellular degradation of proteins asso-
ciated with vasopressin-induced urine concentration [34]. Both
in vivo and in vitro results suggest that the selected three E3s,
BRE1B, NEDD4, and CUL5, could play a potential role in urine
concentration. For example, (1) immunoblots revealed an
increase in NEDD4 and CUL5 during dDAVP withdrawal after
long-term stimulation or an increase in NEDD4 and BRE1B in
rats with lithium-induced NDI; and (2) siRNA-mediated gene
silencing of NEDD4 or CUL5 signiﬁcantly decreased the rate of
AQP2 degradation in mpkCCDc14 cells [34].Other signal transduction pathways involved in
vasopressin regulation of AQP2 trafﬁcking
Other signal transduction pathways including prostaglandins,
angiotensin II, aldosterone, PI3K/Akt pathways, cytoskeleton,
intracellular Ca2+ concentration, and vesicle-targeting receptors
have been described in previous studies and reviews [22,67–69].
Prostaglandins are associated with retrieval of AQP2 from the
plasma membrane, but this appears to be independent of AQP2
phosphorylation by PKA [67]. Angiotensin II has a crosstalk to the
vasopressin-induced signaling transduction pathways for AQP2
trafﬁcking/expression [70–72]. Phosphorylation of other cytoplas-
mic or vesicular regulatory proteins may also be involved. These
issues remain to be investigated directly. The PI3K/Akt pathways
are activated in response to AVP stimulation and are also
importantly involved in the regulation of AQP2 trafﬁcking throughRab GTPase activity of AS160 [36,73]. The cytoskeleton has been
known to be involved in the AQP2 trafﬁcking in kidney collecting
duct [74]. In particular, a microtubular network has been impli-
cated in this process, because chemical disruption of microtubules
inhibits the increase in permeability in both the toad bladder and
the mammalian collecting duct [75,76]. The intracellular Ca2+
concentration has been shown to increase upon stimulation of
isolated perfused rat IMCDs with vasopressin or dDAVP [77]. These
observations have been followed by a number of studies concern-
ing the role of the Ca2+ concentration in the vasopressin-induced
increase in water permeability [78]. The mechanism by which
AQP2 vesicles are targeted to the apical plasmamembrane and the
mechanism by which cAMP controls docking and fusion of
vesicles has been investigated [79,80]. Vesicle-targeting receptors
(often referred to as SNAREs) are believed to induce speciﬁc
interaction of vesicles with membrane sites. Vesicle-targeting
receptors chieﬂy associated with translocating vesicles are known
as VAMPs (vesicle-associated membrane proteins, also referred to
as synaptobrevins) and synaptotagmins. Two other families of
membrane proteins are believed to serve as receptors in target
membranes, namely the syntaxins and SNAP-25 homologs. Sev-
eral of these SNAREs have been found in the renal collecting duct
[63,81–86]. Although numerous vesicle docking and fusion pro-
teins are associated with AQP2, their importance remains
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